Research Article
Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study
Table 1
Baseline characteristics of study patients.
| Number of eyes | 30 eyes of 23 patients |
| Demographics factors | or (%) | Age (years) | | Sex, male | 19 (63.33) | Female | 11 (36.66) | DM duration (years) | | HbA1C (%) | | Medication, insulin | 4 (13.33) | OHA | 26 (86.66) |
| Ocular factors | | DMR severity | | NPDR | 18 (60.00) | PDR | 12 (40.00) | Previous treatment history | | Vitrectomy+PRP | 4 (13.33) | Bevacizumab+PRP | 5 (16.66) | Bevacizumab only | 5 (16.66) | PRP only | 8 (26.66) | Treatment-naïve | 8 (26.66) |
|
|
SD: standard deviation; N: number; DM: diabetes mellitus; HbA1c: glycated hemoglobin; OHA: oral hypoglycemic agents; DMR: diabetic retinopathy; (N)PDR: (non)proliferative diabetic retinopathy; PRP: panretinal photocoagulation.
|